A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

Autor: Kotecha, Ritesh R. a, e, ⁎, Doshi, Sahil D. a, Knezevic, Andrea b, Chaim, Joshua c, Chen, Yingbei d, Jacobi, Rachel a, Zucker, Mark b, Reznik, Ed b, McHugh, Deaglan a, e, Shah, Neil J. a, e, Feld, Emily a, e, Aggen, David H. a, e, Rafelson, William a, e, Xiao, Han a, e, Carlo, Maria I. a, e, Feldman, Darren R. a, e, Lee, Chung-Han a, e, Motzer, Robert J. a, e, Voss, Martin H. a, e, ⁎
Zdroj: In European Urology Oncology August 2024 7(4):804-811
Databáze: ScienceDirect
Externí odkaz: